(AKZA) Akzo Nobel - Ratings and Ratios
Exchange: AS • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0013267909
AKZA: Paints, Coatings, Varnishes, Lacquers, Specialty Coatings
Akzo Nobel N.V., headquartered in Amsterdam, stands as a significant player in the global paints and coatings industry, tracing its roots back to 1646. This companys enduring presence underscores its adaptability and resilience, crucial traits for any investment consideration.
The companys operations are divided into two main segments: Decorative Paints and Performance Coatings. Decorative Paints focuses on products for the building and renovation sectors, offering a range of solutions that enhance both aesthetics and durability. Performance Coatings, on the other hand, caters to industrial applications, providing protective layers for various substrates, from ships to consumer goods, ensuring longevity and performance in demanding environments.
Akzo Nobels brand portfolio is extensive, featuring over 40 brands such as Dulux, Sikkens, and International, each serving different markets and geographies. This diversification not only broadens their market reach but also mitigates risks associated with reliance on a single brand or region, offering investors a layer of stability.
Financially, Akzo Nobel presents a mixed picture. With a market capitalization of 9816.72M EUR, it indicates a substantial presence in its industry. The P/E ratio of 18.19 suggests that investors are willing to pay a premium for its earnings, potentially reflecting confidence in its growth prospects. The forward P/E of 13.46 hints at anticipated earnings growth, aligning with industry expectations. The P/S ratio of 0.92 indicates moderate revenue efficiency, while a P/B ratio of 2.07 shows that investors value its assets at twice its book value, possibly due to strong brand equity and intangible assets.
The companys commitment to innovation is evident through its robust R&D efforts, focusing on sustainable solutions. Akzo Nobels dedication to eco-friendly practices, such as developing water-based and powder coatings, aligns with global sustainability trends, positioning it well for future growth. This strategic focus not only addresses environmental concerns but also meets evolving customer demands, enhancing its competitive edge.
Additional Sources for AKZA Stock
AKZA Stock Overview
Market Cap in USD | 10,414m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception |
AKZA Stock Ratings
Growth 5y | -27.6% |
Fundamental | 14.4% |
Dividend | 58.0% |
Rel. Strength Industry | -8.22 |
Analysts | - |
Fair Price Momentum | 53.08 EUR |
Fair Price DCF | 31.69 EUR |
AKZA Dividends
Dividend Yield 12m | 6.04% |
Yield on Cost 5y | 5.60% |
Annual Growth 5y | 0.62% |
Payout Consistency | 92.2% |
AKZA Growth Ratios
Growth Correlation 3m | 10.7% |
Growth Correlation 12m | -46.1% |
Growth Correlation 5y | -58.2% |
CAGR 5y | -0.24% |
CAGR/Max DD 5y | -0.01 |
Sharpe Ratio 12m | -0.33 |
Alpha | -16.93 |
Beta | 0.51 |
Volatility | 27.05% |
Current Volume | 655k |
Average Volume 20d | 543.5k |
As of March 06, 2025, the stock is trading at EUR 59.98 with a total of 654,989 shares traded.
Over the past week, the price has changed by -0.89%, over one month by +7.96%, over three months by +2.18% and over the past year by -6.65%.
Neither. Based on ValueRay Fundamental Analyses, Akzo Nobel is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 14.41 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AKZA as of March 2025 is 53.08. This means that AKZA is currently overvalued and has a potential downside of -11.5%.
Akzo Nobel has no consensus analysts rating.
According to ValueRays Forecast Model, AKZA Akzo Nobel will be worth about 59.7 in March 2026. The stock is currently trading at 59.98. This means that the stock has a potential downside of -0.45%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 70.5 | 17.5% |
Analysts Target Price | - | - |
ValueRay Target Price | 59.7 | -0.5% |